PORCELLI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.300
AS - Asia 820
EU - Europa 709
SA - Sud America 250
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 53
OC - Oceania 4
Totale 4.281
Nazione #
US - Stati Uniti d'America 2.219
SG - Singapore 316
IT - Italia 221
BR - Brasile 203
CN - Cina 161
RU - Federazione Russa 120
SE - Svezia 110
HK - Hong Kong 95
VN - Vietnam 73
DE - Germania 66
GB - Regno Unito 48
FR - Francia 47
CA - Canada 43
FI - Finlandia 28
IN - India 26
CI - Costa d'Avorio 24
BD - Bangladesh 23
BE - Belgio 21
ID - Indonesia 19
TR - Turchia 16
AR - Argentina 15
IQ - Iraq 14
JP - Giappone 13
AT - Austria 10
MX - Messico 9
VE - Venezuela 9
ZA - Sudafrica 9
CO - Colombia 8
UZ - Uzbekistan 8
NL - Olanda 7
PL - Polonia 7
CR - Costa Rica 6
EC - Ecuador 6
LT - Lituania 6
PH - Filippine 6
PK - Pakistan 6
TN - Tunisia 6
KR - Corea 5
AE - Emirati Arabi Uniti 4
CW - ???statistics.table.value.countryCode.CW??? 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
SV - El Salvador 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
ES - Italia 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
PR - Porto Rico 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
MV - Maldive 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CV - Capo Verde 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NR - Nauru 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.141
Città #
Ashburn 267
Fairfield 221
Singapore 172
Woodbridge 167
San Jose 158
Chandler 154
Hong Kong 95
Houston 95
Seattle 92
Cambridge 87
Nyköping 83
Milan 68
Wilmington 68
Beijing 63
Ann Arbor 49
New York 46
Council Bluffs 41
Bari 40
Los Angeles 34
Ho Chi Minh City 28
Abidjan 24
Lawrence 24
Brooklyn 23
Dallas 23
Munich 23
Roxbury 23
Lauterbourg 22
Brussels 21
Rome 21
São Paulo 21
Santa Clara 18
Columbus 17
Hanoi 15
London 14
Moscow 14
Chicago 13
Helsinki 13
The Dalles 13
Tokyo 13
Boardman 12
Des Moines 12
Jakarta 12
Nanjing 12
Paris 11
San Diego 10
Baghdad 9
Dearborn 9
Montreal 9
North Bergen 9
Turku 9
Falkenstein 8
Atlanta 7
Denver 7
Orem 7
Shanghai 7
Tashkent 7
Toronto 7
Vienna 7
Warsaw 7
Brasília 6
Buffalo 6
Calgary 6
Dong Ket 6
Inglewood 6
Miami 6
Monmouth Junction 6
Phoenix 6
San Francisco 6
Amsterdam 5
Ankara 5
Charlotte 5
Chennai 5
Frankfurt am Main 5
Ottawa 5
Poplar 5
Porto Alegre 5
San José 5
Washington 5
Belo Horizonte 4
Chandigarh 4
Detroit 4
Falls Church 4
Figino 4
Johannesburg 4
Marseille 4
Memphis 4
Nanchang 4
Napoli 4
Pune 4
Rio de Janeiro 4
Willemstad 4
Amman 3
Baku 3
Barranquilla 3
Changsha 3
Curitiba 3
Dhaka 3
Goiânia 3
Guayaquil 3
Haiphong 3
Totale 2.744
Nome #
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 235
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 209
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 206
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 203
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 192
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives 187
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 186
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence 172
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence 172
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 166
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 156
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy 156
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 156
Synthetic lethality to overcome cancer drug resistance 154
p53 as the main traffic controller of the cell signaling network 140
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 140
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer 122
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy 119
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 112
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 109
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study 109
Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach 108
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 103
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 98
IRISIN AND METASTATIC MELANOMA: SELECTIVE ANTI-INVASIVENESS ACTIVITY IN BRAF WILD-TYPE CELLS 95
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 91
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab 87
null 86
The role of non-coding RNAs as prognostic factor, predictor of drug response or resistance and pharmacological targets, in the cutaneous squamous cell carcinoma 83
null 71
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids 58
Totale 4.281
Categoria #
all - tutte 17.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022219 0 0 0 3 21 30 10 15 20 22 29 69
2022/2023393 38 66 26 41 31 51 10 41 64 3 9 13
2023/2024149 16 19 14 11 23 42 2 8 4 3 0 7
2024/2025703 30 13 31 41 40 53 138 80 33 25 71 148
2025/20261.399 218 69 96 140 181 70 107 39 179 134 48 118
2026/2027316 38 52 87 139 0 0 0 0 0 0 0 0
Totale 4.281